No. of studies | Design | Quality assessment | No. of patients | Â | Â | Effect | Quality | Importance | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Risk of bias | Inconsistency | Indirectness | Imprecision | Other | Treatment | Control | Relative (95% CI) | Absolute | Â | Â | ||
Effective Rate (Measured with: CCDM-3,PSQI et al.) | ||||||||||||
8 | RCT | very serious1 | no serious inconsistency | no serious indirectness | no serious imprecision | none4 | 268/293 (91.5%) | 208/282 (73.8%) | RR 1.24 (1.15 ~ 1.35) | 177/1000 (111 ~ 258) | LOW | CRITICAL |
61.29% | 147/1000 (92 ~ 215) | |||||||||||
85.71% | 206/1000 (129 ~ 300) | |||||||||||
Sleep Efficiency % (Measured with: International Standard Sleep Efficiency; Better indicated by higher values) | ||||||||||||
1 | RCT | serious1 | serious2 | no serious indirectness | serious 3 | none4 | 36 | 36 | — | MD 21.44 (16.30 ~ 26.58) | VERY LOW | IMPORTANT |
Global Score On PAQI points (Measured with: PSQI; range of scores: 0-21; Better indicated by lower values) | ||||||||||||
1 | RCT | serious1 | serious2 | no serious indirectness | serious 3 | none4 | 32 | 31 | — | MD -3.62 (-4.59 ~ -2.65) | VERY LOW | CRITICAL |
Adverse Effect (Assessed with: SCL-90, TESS et al.) | ||||||||||||
4 | RCT | very serious1 | no serious inconsistency | no serious indirectness | no serious imprecision | none4 | 4/174 (2.3%) | 45/164 (27.4%) | RR 0.11 (0.04 ~ 0.26) | 244/1000 (203 ~ 263) | LOW | IMPORTANT |
8.62% | 77/1000 (64 ~ 83) | |||||||||||
62.50% | 556/1000 (463 ~ 600) |